PDA issues advisory on ‘Paxlovid’ antiviral treatment for non-hospitalised patients
The Pharmacists’ Defence Association (PDA) has issued an advisory information to community pharmacy contractors about Paxlovid antiviral treatment for non-hospitalised patients.
“Patients will be assessed...
MHRA approves second oral Covid-19 antiviral, Paxlovid
UK regulator has approved a second oral antiviral for early treatment of Covid-19 in high-risk adults, after molnupiravir called Paxlovid.
The Medicines and Healthcare products Regulatory...